Learning Lab | Recipe for Success: How Integrated MIDD & AI Approaches Can Accelerate Obesity Drug Development brought to you by Simulations Plus

Partner Presenter(s)

• DS

  David C. Sperry, PhD

  Executive Director, Synthetic Molecule Design & Development
  Eli Lilly & Co.
• 

  Amparo de la Peña, PhD

  Vice President, Pharmacometric Services
  Simulations Plus, Inc.
• 

  Scott Q. Q. Siler, PhD

  Chief Science Officer, QSP
  Simulations Plus, Inc.
• 

  Maxime Le Merdy, PharmD, PhD (he/him/his)

  Director, PBPK Research & Collaborations
  Simulations Plus, Inc.
• 

  Sandra Suarez-Sharp, PhD

  President, Regulatory Center of Excellence
  Simulations Plus, Inc.
• 

  Jill Fiedler-Kelly, FISoP

  President, CPP Services
  Simulations Plus, Inc.
• 

  Feng Yang, PhD

  Executive Director, Pharmacometrics
  Structure Therapeutics

Learning Labs have limited capacity and rooms will fill up quickly! Arrive early to ensure you can secure your spot.

The global obesity drug market is projected to grow to $37.94 billion by 2032, driven largely by the drugs currently in development. The pace of development is fierce, and sponsors aiming to compete must leverage all available tools to optimize efficacy, minimize side effects, and accelerate development timelines. Model-informed drug development (MIDD) and artificial intelligence (AI) can assist in achieving these goals. In this one-hour Learning Lab, attendees will follow the development process of a drug candidate targeting obesity, from the early stages of discovery through pre-clinical and clinical development.

The panel of experts will explain the technology and methodologies available to design and prioritize drug candidates, identify dosing strategies that optimize efficacy and minimize safety concerns, and design protocols that increase the likelihood of clinical success and regulatory approval. They will also discuss how predictions generated in earlier stages can inform MIDD choices and support decision-making in later phases of development.

Attendees will have the opportunity to ask questions throughout the interactive panel discussion, while they enjoy a light lunch.

Brought to you by:



This event is sponsored by an ASCPT Partner organization. The content of the session is provided for informational purposes only and does not constitute or imply ASCPT's endorsement, recommendation, or approval of a specific institution, service, employer, or content.